Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Algatech is a leading biotechnology company specializing in the commercial cultivation of microalgae and the production of high-value natural ingredients for the nutraceutical, cosmeceutical, and functional food industries. Based in Israel's Arava Desert, the company utilizes a proprietary, closed-system tubular photobioreactor technology that leverages intense solar radiation to produce high-purity algae in a controlled environment. Its flagship product, AstaPure, is a premium natural astaxanthin recognized for its potent antioxidant properties and is used in a wide range of health supplements and skincare products. In addition to astaxanthin, Algatech produces Fucovital, a fucoxanthin complex for metabolic health, and BioGlena, a whole-algae beta-glucan for immune support. The company was acquired by the Solabia Group in 2019, which has further integrated Algatech's sustainable microalgae solutions into a global distribution network.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Algatech.